Cargando…
Renin-angiotensin system inhibitors mitigate radiation pneumonitis by activating ACE2-angiotensin-(1–7) axis via NF-κB/MAPK pathway
Radiation pneumonitis (RP) affects both patients and physicians during radiation therapy for lung cancer. To date, there are no effective drugs for improving the clinical outcomes of RP. The activation of angiotensin-converting enzyme 2 (ACE2) improves experimental acute lung injury caused by severe...
Autores principales: | Cong, Changsheng, Niu, Shiying, Jiang, Yifan, Zhang, Xinhui, Jing, Wang, Zheng, Yawen, Zhang, Xiaoyue, Su, Guohai, Zhang, Yueying, Sun, Meili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204016/ https://www.ncbi.nlm.nih.gov/pubmed/37221286 http://dx.doi.org/10.1038/s41598-023-35412-0 |
Ejemplares similares
-
Decreased risk of radiation pneumonitis with concurrent use of renin-angiotensin system inhibitors in thoracic radiation therapy of lung cancer
por: Zheng, Yawen, et al.
Publicado: (2023) -
Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system
por: Guang, Cuie, et al.
Publicado: (2012) -
ACE2, a new regulator of the renin–angiotensin system
por: Burrell, Louise M., et al.
Publicado: (2004) -
Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020) -
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
por: Sackin, Henry
Publicado: (2021)